E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation
文献类型：期刊论文
| 作者 | Zijia Ren2; Wenyao Kang2; Lihua Wang4; Baoliang Sun1; Jiajia Ma2; Chaogu Zheng2; Jie Sun2; Zhigang Tian2; Xiaoyi Yang1; Weihua Xiao2 |
| 刊名 | Molecular Cancer
 |
| 出版日期 | 2014 |
| 卷号 | 13 |
| ISSN号 | 1476-4598 |
| 英文摘要 | E2F1 is the gatekeeper of the cell cycle controlling an analogous balance between proliferation and cell death. E2F1 expression is elevated in advanced prostate cancer. However, it is still unclear that the roles and mechanisms of E2F1 on prostate cancers. |
| 语种 | 英语 |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/124197]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Taishan Medical College 2.中国科学技术大学 3.Hefei Institutes of Physical Science, Chinese Academy of Sciences 4.Affiliated Hospital of Weifang Medical College |
| 推荐引用方式 GB/T 7714 | Zijia Ren,Wenyao Kang,Lihua Wang,et al. E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation[J]. Molecular Cancer,2014,13. |
| APA | Zijia Ren.,Wenyao Kang.,Lihua Wang.,Baoliang Sun.,Jiajia Ma.,...&Weihua Xiao.(2014).E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation.Molecular Cancer,13. |
| MLA | Zijia Ren,et al."E2F1 renders prostate cancer cell resistant to ICAM-1 mediated antitumor immunity by NF-κB modulation".Molecular Cancer 13(2014). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。